Search For "phase 3 trial"
COVAXIN phase 3 full trial data will be made public in July: Bharat Biotec
Updated : 4 years, 11 months ago IST
New Delhi [India], June 9 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in July following that the company will be applying for the full licensure of COVAXIN.
Read More
China's Sinopharm publishes awaited COVID vaccine trial data; fails to cov
Updated : 5 years ago IST
Beijing [China], May 27 (ANI): The Chinese drug maker Sinopharm has finally published the interim results of a phase 3 trial of its COVID-19 vaccine, however, the results do not cover some of the most vulnerable groups.
Read More
Regeneron antibody cocktail 'helps prevent' symptomatic Covid-19: Drugmake
Updated : 5 years, 1 month ago IST
New York [US], April 13 (ANI): New Phase 3 trial data finds a single shot of Regeneron's Covid-19 antibody cocktail was able to prevent symptomatic Covid-19 among people exposed to the virus, the company said on Monday.
Read More
Russia's Sputnik V COVID-19 vaccine 91.6 per cent effective: Lancet
Updated : 5 years, 4 months ago IST
Moscow [Russia], February 2 (ANI): Russian's Sputnik V is 91.6 per cent effective at protecting people from COVID-19, according to the result of an interim analysis of the phase 3 trials published by the journal Lancet on Tuesday.
Read More
COVID-19 vaccine of US company Novavax shows 89.3 pc efficacy in phase 3 t
Updated : 5 years, 4 months ago IST
Maryland [US], January 29 (ANI/Sputnik): The coronavirus vaccine developed by the US company Novavax has demonstrated 89.3 per cent efficacy during the phase 3 trials conducted in the United Kingdom, the company said in a statement.
Read More
Russian COVID-19 vaccine in phase 3 trial, to cost below USD 10 per shot i
Updated : 5 years, 4 months ago IST
New Delhi [India], January 21 (ANI): The Russian COVID-19 vaccine 'Sputnik V' will cost less than USD 10 (about Rs 730) per shot in India and the price is the same for all countries, Kirill Dmitriev, CEO of Russian Direct Investment Fund (RDIF) said on Thursday.
Read More
Indians are not guinea pigs, you can't use Covaxin rollout as phase 3 tria
Updated : 5 years, 4 months ago IST
New Delhi [India], January 14 (ANI): Congress leader Manish Tewari on Wednesday said that emergency use authorization to COVID-19 vaccine 'Covaxin' raises concerns on its efficacy as phase three trials have not been completed and its roll out can't be used as phase three trial. He said India
Read More
Approval to Covaxin premature, could be dangerous: Tharoor
Updated : 5 years, 5 months ago IST
New Delhi [India], January 3 (ANI): Senior Congress leader Shashi Tharoor on Sunday said that the emergency approval to COVID-19 vaccine--Covaxin is premature and could be dangerous as it is still under phase 3 trial. He urged Union Health Minister Dr Harsh Vardhan to wait till full trials o
Read More
US launches Phase 3 trial of 2 new antibody treatments for COVID-19
Updated : 5 years, 5 months ago IST
Washington [US], December 18 (ANI): The United States, on Thursday, announced phase 3 clinical trials of two experimental drugs to treat hospitalized COVID-19 patients when combined with existing treatments, said the National Institute for Allergy and Infectious Diseases (NIAID) (local time
Read More
Sputnik V vaccine efficacy confirmed at '91.4 per cent' during Phase 3 tri
Updated : 5 years, 5 months ago IST
Moscow [Russia], December 14 (ANI): The efficacy of the Sputnik V COVID-19 vaccine has been confirmed to be 91.4 per cent, based on data analysis of the final control point of clinical trials, announced the Gamaleya National Center of Epidemiology and Microbiology and the Russian Direct I
Read More
'Got only first dose of coronavirus vaccine, antibodies develop after 2 do
Updated : 5 years, 5 months ago IST
New Delhi [India], December 6 (ANI): Haryana Home Minister Anil Vij who tested positive for Covid-19 on December 5 and is hospitalized said on Sunday that he was told by doctors before being administered the first dose during the phase 3 trial of Bharat Biotech's coronavirus vaccine Covaxin
Read More
Sola Civil Hospital in Ahmedabad begins Phase-3 trial of Covaxin
Updated : 5 years, 6 months ago IST
Ahmedabad (Gujarat) [India], November 27 (ANI): The Phase-3 trial of COVID-19 vaccine candidate Covaxin begun with five volunteers at Sola Civil Hospital in Ahmedabad on Thursday.
Read More